To scroll text in this page

Global Navigation
Global Navigation end

link:Investor Relations

Start of the main text
Welcome to our IR web site. Here, we provide easy-to-understand explanations of Astellas' business performance and operations.
  • link:Message from CEO
IR News
  • RSS
  • Previous data
February 02, 2010
Posted Financial Results for 3Q/FY2009
February 02, 2010
Updated "IR Calendar" Section
January 29, 2010
Theravance Inc. announced that it received a letter indicating that Theravance's response to the Complete Response letter for the injectable antibiotic telavancin for the treatment of nosocomial pneumonia is incomplete.
  • link:Message from CEO "Business Philosophy, Vision, Medium-Term Plan, CSR-Based Management and others"
  • link:Financial Information"Financial Highlights, Financial Statements, Segment Information and others"
  • link:Stock and Bond Information"Shareholders' Meeting, Shareholder Return and others"
  • link:IR Library"Business Results, Overview of R&D Pipeline, Presentation Materials and others"
  • link:IR Calendar"IR Event Schedule"
  • link:Analyst Coverage"List of security analysts"

(Last Update: February 2, 2010)

Main Text end
Local Navigation
Local Navigation end
Related Links